Postoperative management of stage II/III colon cancer: A decision analysis
- 1 October 1999
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 117 (4) , 784-793
- https://doi.org/10.1016/s0016-5085(99)70335-5
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.Journal of Clinical Oncology, 1997
- Adjuvant chemotherapy in colorectal carcinomaDiseases of the Colon & Rectum, 1997
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Follow-Up of Patients with Colorectal Cancer A Meta-AnalysisAnnals of Surgery, 1994
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- Survival in patients with large-bowel cancerDiseases of the Colon & Rectum, 1990
- The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathologyCancer, 1987
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigatorsPublished by Elsevier
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965